Radial artery conduits for coronary artery bypass grafting: Current perspective  by Mussa, Shafi et al.
Editorials Mussa, Choudhary, Taggart
ED
ITO
RIA
LRadial artery conduits for coronary artery bypass grafting:
Current perspective
Shafi Mussa, MA, MRCS
Bikram P. Choudhary, MRCS
David P. Taggart, MD(Hons), PhD, FRCSFrom the Department of Cardiothoracic
Surgery, John Radcliffe Hospital, Oxford,
United Kingdom.
Received for publication June 27, 2004;
revisions received July 23, 2004; accepted
for publication July 28, 2004.
Address for reprints: David P. Taggart,
MD(Hons), PhD, FRCS, Professor of
Cardiovascular Surgery, University of
Oxford, and Consultant Cardiothoracic
Surgeon, John Radcliffe Hospital, Heading-
ton, Oxford OX3 9DU, UK (E-mail: david.
taggart@orh.nhs.uk).
J Thorac Cardiovasc Surg 2005;129:250-3
0022-5223/$30.00
Copyright © 2005 by The American Asso-
ciation for Thoracic Surgery
A supplemental list of refer-
ences is available online.doi:10.1016/j.jtcvs.2004.07.040
250 The Journal of Thoracic and CardioTotal arterial revascularization offers the potential to avoid the prob-lems associated with vein graft failure. Bilateral internal thoracicarteries (ITAs) are the conduits of first choice because of excellentshort- and long-term patency and the possibility of improved sur-vival.1 The radial artery (RA) is easily harvested, versatile, hasexcellent handling characteristics, and has become the arterial con-
duit of third choice.2 Issues remain concerning its optimal use, however, particularly
with reference to preoperative assessment, harvesting techniques, vasospasm pro-
phylaxis, grafting strategy, and long-term patency. This article critically examines
the current evidence for these important aspects of RA use.
Preoperative Assessment
Preoperative assessment of the RA and collateral hand circulation is mandatory to
avoid hand ischemia in patients with an inadequate collateral circulation. The most
widely used clinical test for assessment of adequate collateral circulation to the hand
is the modified Allen test. In our own practice, 85% of patients have the RA safely
harvested after clinical assessment only.3 In the remaining 15% with equivocal or
positive Allen tests, further imaging is performed with duplex ultrasonography,
which combines pulsed Doppler with a B-mode imager to record vessel flow
velocity, vessel caliber and anatomic variations, and severity of atherosclerotic
lesions along the entire length of the vessel. Use of bilateral forearm duplex
scanning when clinical assessment is equivocal has enabled the use of RA conduits
in 99% of patients scheduled for total arterial coronary artery bypass grafting
(CABG).3
Concern about the reliability of the Allen test has prompted evaluation of other
assessment techniques, such as digital pulse oximetry, digital plethysmography, and
Doppler ultrasonographic methods. However, there is no convincing evidence that
these result in improved clinical outcomes after RA harvest.
Harvesting Technique
Improved harvesting techniques are fundamental to the current success of radial
grafts in CABG. Further refinements may result in improvements to graft function,
reduced complications, and greater patient satisfaction. The options available for
RA harvesting are pedicled versus skeletonized, ultrasonic scalpel versus traditional
dissection, and open versus endoscopic harvest. Although several studies have
compared harvesting techniques, none has been sufficiently robust in methodology
or sufficiently powered to detect clinically relevant differences between the tech-
niques, assuming that these exist. A comparison of early angiographic patency of
ultrasonic harvested skeletonized versus traditionally harvested pedicled RA con-
duits demonstrated better patency for skeletonized conduits (97%) than pedicled
conduits (85%). Whether these findings reflect the ease of use of skeletonized
conduits or the impact of the ultrasonic scalpel, rather than the true effect of
skeletonization, remains uncertain. Graft blood flow has been shown to be similar in
skeletonized and pedicled conduits, independent of method of harvest. Although
significantly greater blood flow has been reported in conduits harvested with
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ference has been demonstrated in structural or functional
endothelial integrity between RA harvested with electrocau-
tery or ultrasonic scalpel.
Requirements for improved aesthetics, accelerated re-
covery, and greater patient satisfaction have encouraged
endoscopic conduit harvesting in CABG. For endoscopic
RA harvest, three or fewer 2-cm incisions at the wrist,
elbow, and mid forearm are usually all that are required. In
contrast, the open technique requires a curvilinear skin
incision extending along the length of the forearm. Cer-
tainly, endoscopic harvest takes longer than open harvest,
carries a similar incidence of dorsal thenar paresthesia, and
yields no advantages in terms of wound infection. Despite
there being no proven clinical advantage, however, increas-
ing experience and evolving technology is likely to encour-
age the pursuit of endoscopic techniques. Disadvantages
include increased equipment costs and the requirement for
specific training.
Vasospasm Prophylaxis
Vasospasm has been reported in 4% to 10% of all RA grafts.
This may have potentially significant adverse consequences
in terms of perioperative myocardial infarction and low
cardiac output syndrome and its sequelae, including ex-
tended intensive care stays and increased mortality. Phar-
macologic prevention of RA spasm has been fundamental to
its revival as a conduit for CABG. Clinically useful agents
should ideally be effective against a wide variety of endog-
enous vasoconstrictor substances liberated because of sur-
gical stress or the inflammatory response to cardiopulmo-
nary bypass, as well as exogenously administered inotropes
or vasoconstrictors. Furthermore, antispasmodic activity
should ideally be maintained throughout the immediate
postoperative period. Finally, the agent should neither cause
local injury to the conduit nor have harmful systemic ef-
fects. Currently no agents, alone or in combination, can be
defined as an ideal antispasmodic, warranting continued
development of vasodilator strategies for RA grafts.
Antispasmodic agents can be applied topically or deliv-
ered systemically. Topical application of vasodilator agents
is convenient and reduces the incidence of the adverse
consequences of systemic administration; for example, dil-
tiazem may counteract vasospasm but can precipitate he-
modynamic instability through bradycardia, atrioventricular
block, and hypotension. Nitroglycerin infusions may be
safer and more effective at preventing conduit spasm after
CABG than diltiazem but can cause peripheral vasodilata-
tion and are unsuitable for patients with hemodynamic
instability. Systemic milrinone may be particularly benefi-
cial in low cardiac output situations, although it frequently
causes hypotension, necessitating vasoconstrictor infusions
to maintain hemodynamic stability.
The Journal of ThoraciTopical pharmacologic preparations in current use fall
into three broad categories: phosphodiesterase inhibitors,
calcium-channel antagonists, and -adrenergic antagonists.
Papaverine, a short-acting phosphodiesterase inhibitor, is a
widely used topical vasodilator for arterial conduits. How-
ever, in vitro studies demonstrate that the efficacy of pa-
paverine diminishes after 30 minutes.4 Thus papaverine
may ameliorate spasm during RA harvest but not through-
out the intraoperative and immediate postoperative period.
Additionally, the preparation is acidic and may damage the
endothelium. Milrinone, a longer-acting phosphodiesterase
inhibitor found to be a potent vasodilator of RA segments in
vitro, has been administered intraluminally to prevent graft
spasm with good clinical results. Verapamil and nitroglyc-
erin in combination (VG solution) rapidly and effectively
prevents spasm against a wide range of vasoconstrictors,5
with improved preservation of endothelial function relative
to papaverine. In vitro studies from our group demonstrate
that the antispasmodic effect of this combination is largely
abolished after 4 hours.4
Phenoxybenzamine, a nonselective -adrenoceptor an-
tagonist, prevents catecholamine-mediated RA vasocon-
striction,4 has a duration of action as long as 18 hours in
vitro, and is less harmful to the endothelium than papaver-
ine. However, phenoxybenzamine has no activity against
noncatecholamine vasoconstrictors released in response to
surgical stress or cardiopulmonary bypass that also may
encourage RA vasospasm.4 Consequently, in our practice
we currently use a solution of phenoxybenzamine (2 mg/
mL) and verapamil (0.1 mg/mL) in heparinized blood, ap-
plied intraluminally and topically to the harvested conduit.
Oral calcium-channel antagonists have been recom-
mended for as long as 1 year after surgery for those patients
receiving RA grafts, to prevent delayed vasospasm. In a
randomized trial, continuation of diltiazem beyond 1 year in
patients with RA grafts provided no additional benefit in
terms of clinical and angiographic outcomes.
Grafting Strategy
Optimal placement of radial artery grafts to achieve satis-
factory long-term patency remains controversial. The con-
cept of competitive flow suggests that graft flow is influ-
enced by native coronary flow. Grafted conduits may
therefore fare better in conditions of poor native coronary
flow, typified by high-grade coronary stenoses. There is
accumulating evidence that grafting the RA to coronary
targets with moderate stenoses (70%) results in reduced
anastomotic patency.6
Some studies have reported lower angiographic patency
rates for RA grafts to the right coronary artery compared
with the left anterior descending coronary artery.6 This
finding remains controversial, because longer-term studies
c and Cardiovascular Surgery ● Volume 129, Number 2 251
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graft patency.7
Options for the proximal RA anastomosis are most com-
monly to the aorta as an aortocoronary graft or to another
conduit as a composite graft. A comparison of angiographic
patency of RA grafts in the aortocoronary versus composite
configuration approximately 2 years after surgery demon-
strated patency rates of 75% (aortocoronary) versus 70%
(composite). Proximal anastomosis location did not influ-
ence midterm angiographic patency, whereas degree of na-
tive vessel stenosis and choice of target vessel did. The
pedicled left ITA–RA composite graft has a patency rate of
82% to 93% at just under 1 year, comparable to that of
aortocoronary grafts.
Composite grafts have the major advantage of facilitat-
ing a “no-touch” aortic technique in off-pump revascular-
ization, thereby reducing the risk of embolic debris from the
ascending aorta. Potential disadvantages of composite grafts
compared with conventional aorta-coronary RA grafts are
the relative technical difficulty and the reliance on single
inflow (proximal left ITA) to supply all grafted territories.
Midterm and Long-Term Angiographic Patency
Since the 1990s, several series have demonstrated encour-
aging midterm and long-term angiographic results of RA
grafts. Table 1 details the most pertinent data from each
study. Midterm angiographic patency rates vary between
83% and 95%. Long-term angiographic patency is 88%.7
However, the data must be interpreted with caution. All
these studies were retrospective analyses, and the percent-
age of grafts followed up with angiography varies from
3.4% to 92%.7 The quoted patency rates may be based on a
relatively small proportion of RA grafts undergoing re-
peated angiography, usually because of recurrent symp-
toms, and do not necessarily reflect patency rates for the
entire cohort. The assumption that symptom-free patients
are likely to have more patent grafts is logical but does not
justify extrapolation of graft patency rates. The study by
Possati and associates7 with 92% angiographic follow-up to
almost 9 years, irrespective of recurrent symptoms, provides
TABLE 1. RA patency for CABG: Summary of published da
Authors
RA conduits
used
RA conduits
reassessed
Acar et al9 910 64
Possati et al10 325 62
Iaco et al11 164 91*
Tatoulis et al12 8420 280 (369*)
Possati et al7 91 84
Khot13 — 310
*Numbers represent anastomoses reassessed.the most compelling data to date.
252 The Journal of Thoracic and Cardiovascular Surgery ● FebrOf considerable interest is the comparative performance
of RA versus long saphenous vein conduits. Occlusive
disease of vein grafts remains a major limitation of CABG,
with as many as 75% of vein grafts severely stenosed or
occluded at 10 years, although refinements in harvesting
techniques and the use of aspirin and statins may contribute
to improved vein graft performance in contemporary
CABG. Most recently, midterm (1.5 years) angiographic
follow-up of patients with symptoms after CABG has re-
vealed RA patency rates of 51%, compared with 64% for
vein grafts. The results from this retrospective study are in
stark contrast to previous published series but may reflect
selection bias because only patients with symptoms under-
went repeated angiography.
To address some of these issues, three prospective, ran-
domized, controlled trials comparing RA with other con-
duits with the intention of complete angiographic follow-up
are in progress. The results of the Radial Artery Patency
Study (RAPS) and the Radial artery Versus Saphenous vein
Patency study (RSVP), are awaited. Recently, the interim
(5 year) results of the Radial Artery Patency and Clinical
Outcome (RAPCO) study, a prospective, randomized trial
comparing RA with saphenous vein grafts and free right
ITA grafts,8 have been reported. Five-year patency rates
between RA and right ITA are 95% versus 100%, respec-
tively, and those between RA and saphenous vein are 87%
versus 94%, at least according to the small number of
patients who have undergone early repeated angiography.
No statistically significant differences in graft patency have
been demonstrated between RA and other conduits.
Summary and Recommendations
To optimize use of the RA as a coronary bypass conduit:
● Preoperative assessment is mandatory, and the Allen
test is sufficient in most cases. Duplex ultrasonogra-
phy can be used as an imaging adjunct, and can increase
harvest rates toward 100% where appropriate.3
● Several harvesting techniques have been proposed, but
data supporting one method relative to another are
riginal grafts
assessed (%)
Angiographic patency
(FitzGibbon grade A, %)
Follow-up
(y)
7 83 5.6 1.1
19 87 4.9 0.5
47 95 4.0 2.3
3 90 1.2 0.9
92 88 8.8  0.8
— 51 1.5  1.4ta
O
recurrently lacking.
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tions is vital to prevent perioperative graft vasospasm.
Phenoxybenzamine is highly effective against endog-
enous or exogenous (inotrope-induced) -adrenocep-
tor–mediated spasm but should be combined with an
agent with a broader spectrum of action such as vera-
pamil.
● RA grafts exhibit diminished long-term patency if
anastomosed to coronary target vessels with 70%
proximal stenoses. RA conduits may be used in either
an aorta-coronary or composite configuration, with no
impact on patency. The choice of which coronary
target vessel to bypass with RA grafts remains con-
troversial, with evidence available to support either
strategy.
● Ongoing randomized trials will establish the relative
long-term patency of RA conduits compared with the
more established ITA and long saphenous vein.
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